Work

Abstract No. 4 ▪ ABSTRACT OF THE YEAR Preliminary Results of the FRONTIER Trial: Safety and Feasibility of Yttrium-90 TheraSphere in Recurrent Glioblastoma

Year: 2025

Type: conference-abstract

Source: Journal of Vascular and Interventional Radiology

DOI: 10.1016/j.jvir.2024.12.030

Authors: S. Mouli, D. Rivera-Rodriguez, S. Ansari, M. Tate, R. Lukas, J. Weinstein, Y. Serulle, J. Boockvar, K. Narsinh, N. Butowski, M. Dreher, R. Stupp, R. Salem

Institutions: Northwestern Memorial Hospital, Central University of the Caribbean, Northwell Health, Lenox Hill Hospital, University of California, San Francisco, Boston Scientific (United States)

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4407754593

Cites:

Cited by: 3

Related to: 10